Morpholino

MO2-mir7a-3

ID

ZDB-MRPHLNO-201005-4

Name

MO2-mir7a-3

Previous Names

None

Target

mir7a-3 (1)

Sequence

5' - TTGTTGTTGGTTTTTGTTCATTTTC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-mir7a-3

No data available

Phenotype

Phenotype resulting from MO2-mir7a-3

No data available

Phenotype of all Fish created by or utilizing MO2-mir7a-3

Phenotype	Fish	Conditions	Figures
brain GFP expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 6 from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 3 from Adusumilli et al., 2020
brain th expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 6 from Adusumilli et al., 2020
caudal tuberculum ventral region GFP expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 3 from Adusumilli et al., 2020
diencephalon GFP expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 3 from Adusumilli et al., 2020
hypothalamus GFP expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 3 from Adusumilli et al., 2020
diencephalon id3 expression increased amount, abnormal	ia4Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 3 from Adusumilli et al., 2020
diencephalon nr4a2a expression increased amount, abnormal	ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon lmx1bb expression increased amount, abnormal	ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon mCherry expression increased amount, abnormal	ia5Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
telencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
hindbrain EGFP expression decreased amount, abnormal	vu12Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
telencephalon diencephalon boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
brain smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
forebrain midbrain boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020
hypothalamus smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO2-mir7a-1 + MO2-mir7a-2 + MO2-mir7a-3	standard conditions	Figure 8 from Adusumilli et al., 2020

Citations